Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ZIEXTENZO

PEGFILGRASTIM-BMEZ

Standard Dose
6MG/0.6ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview ZIEXTENZO is listed in Drugs@FDA under application 761045 (BLA).

Marketing status: Prescription Active ingredient PEGFILGRASTIM-BMEZ Form and strength INJECTABLE;INJECTION - 6MG/0.6ML Sponsor SANDOZ INC Submission history Latest submission status date: 2024-02-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZIEXTENZO is listed in Drugs@FDA under application 761045 (BLA). Marketing status: Prescription Active ingredient PEGFILGRASTIM-BMEZ Form and strength INJECTABLE;INJECTION - 6MG/0.6ML Sponsor SANDOZ INC Submission history Latest submission status date: 2024-02-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.